Melanion BTC Equities UCITS ETF logo

Melanion BTC Equities UCITS ETF (BTC)

Market Closed
2 Jul, 15:30
XMIL XMIL
14. 81
+0.54
+3.77%
- Market Cap
0% Div Yield
78 Volume
14.28
Previous Close
Day Range
14.4 14.81
Year Range
9.16 22.1
Want to track BTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BTC closed today higher at €14.81, an increase of 3.77% from yesterday's close, completing a monthly increase of 4.72% or €0.67. Over the past 12 months, BTC stock lost -13.92%.
BTC pays dividends to its shareholders, with the most recent payment made on Jun 28, 2024. The next estimated payment will be in 9 months ago on Sep 28, 2024 for a total of €0.19171.
Melanion BTC Equities UCITS ETF has completed 1 stock splits, with the recent split occurring on Nov 20, 2024.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ARCA (USD).

BTC Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Planet Ventures Acquires 3.37939441 Bitcoin (BTC) For Additional CAD $500,000 Purchase

Planet Ventures Acquires 3.37939441 Bitcoin (BTC) For Additional CAD $500,000 Purchase

Company Continues to Add to their Bitcoin Position   Vancouver, BC – July 2, 2025 - TheNewswire – Planet Ventures Inc. (CSE: PXI; OTC: PNXPF) ("Planet Ventures" or the "Company"), an investment issuer focused on technology, mining and digital assets, is pleased to announce that it has completed an additional purchase of 3.37939441 Bitcoin for an aggregate purchase price of $500,000 CAD , using a portion of its existing cash reserves.

Thenewswire | 11 hours ago
Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera® (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera® (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial – DUBLIN , July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Commission (EC) has granted conditional marketing authorization1 for Ziihera ® (zanidatamab), a dual human epidermal growth factor receptor 2 (HER2)-targeted bispecific antibody, as monotherapy for the treatment of adults with unresectable locally advanced or metastatic HER2-positive (IHC 3+)† biliary tract cancer (BTC) previously treated with at least one prior line of systemic therapy.2 BTCs, which include gallbladder cancer (GBC) and cholangiocarcinoma (CCA), are a rare and aggressive group of cancers,3 with most cases diagnosed at an advanced stage4 when curative surgery is no longer an option.5 , 6 , 7 Globally, approximately 26% of patients with BTC are HER2-positive,8 a biomarker associated with poorer outcomes compared to HER2-negative disease.9 Ziihera is the first HER2-targeted therapy given conditional authorization for HER2-positive BTC in the European Union (EU). Continued approval for this indication is contingent upon verification and description of clinical benefit in the ongoing Phase 3 HERIZON-BTC-302 trial, which is evaluating zanidatamab in combination with standard-of-care therapy versus standard-of-care therapy alone in the first-line setting for patients with HER2-positive BTC.10 "People with HER2-positive biliary tract cancer who progress after first-line therapy face a challenging prognosis, with limited treatment options, poor tolerability, and median overall survival of only six to nine months," said Arndt Vogel, MD, managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, Germany.

Prnewswire | 1 day ago
Planet Ventures Acquires 3.40669032 Bitcoin (BTC) For Initial Cad $500,0000 Purchase

Planet Ventures Acquires 3.40669032 Bitcoin (BTC) For Initial Cad $500,0000 Purchase

Company Deploys Excess Cash into Strategic Bitcoin Position   Vancouver, BC – June 27, 2025 – TheNewswire - Planet Ventures Inc. (CSE: PXI; OTC: PNXPF) ("Planet Ventures" or the "Company"), an investment issuer focused on technology, mining and digital assets, is pleased to announce that it has completed its first purchase of 3.40669032 Bitcoin for an aggregate purchase price of $500,000 CAD , using a portion of its existing cash reserves.

Thenewswire | 5 days ago

Melanion BTC Equities UCITS ETF Dividends

Grayscale Bitcoin Trust (BTC) logo
BTC 27 Jun 2024
Paid
Quarterly
$0.19 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 26 Mar 2024
Paid
Quarterly
$0.56 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 27 Dec 2023
Paid
Quarterly
$0.65 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 27 Sep 2023
Paid
Quarterly
$0.93 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 28 Jun 2023
Paid
Quarterly
$0.17 Per Share

Melanion BTC Equities UCITS ETF Earnings

BTC have yet to publish their earning reports.
Grayscale Bitcoin Trust (BTC) logo
BTC 27 Jun 2024
Paid
Quarterly
$0.19 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 26 Mar 2024
Paid
Quarterly
$0.56 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 27 Dec 2023
Paid
Quarterly
$0.65 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 27 Sep 2023
Paid
Quarterly
$0.93 Per Share
Grayscale Bitcoin Trust (BTC) logo
BTC 28 Jun 2023
Paid
Quarterly
$0.17 Per Share
BTC have yet to publish their earning reports.

Melanion BTC Equities UCITS ETF (BTC) FAQ

What is the stock price today?

The current price is €14.81.

On which exchange is it traded?

Melanion BTC Equities UCITS ETF is listed on ARCA.

What is its stock symbol?

The ticker symbol is BTC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

Has Melanion BTC Equities UCITS ETF ever had a stock split?

Melanion BTC Equities UCITS ETF had 1 splits and the recent split was on Nov 20, 2024.

Melanion BTC Equities UCITS ETF Profile

XMIL Exchange
US Country

Overview

The fund discussed is an actively managed exchange-traded fund (ETF) that focuses on achieving its investment objective through a strategic portfolio of debt securities and debt-like instruments. By committing at least 80% of its net assets, along with any borrowings meant for investment purposes, this fund specifically targets debt securities that are economically akin to traditional debt instruments. The emphasis is on investing in instruments that are denominated in U.S. dollars and fall within the investment-grade category, highlighting the fund's preference for relatively safer, high-quality debt securities. Furthermore, the fund aims to manage its portfolio in a way that maintains a dollar-weighted average maturity ranging from zero to ten years, optimizing its balance between yield and maturity risk.

Products and Services

  • Debt Securities Investment

    This service comprises the primary focus of the fund, where it invests in a variety of debt securities. These securities are chiefly denominated in U.S. dollars and are carefully selected to meet the fund's investment-grade requirement. By investing in these securities, the fund seeks to provide investors a stable and possibly lucrative return, derived from interest income and the potential for capital appreciation, all within the confines of maintaining a relatively low-risk investment posture.

  • Active Portfolio Management

    As an actively managed ETF, the fund employs a strategic approach to managing its portfolio, with investment decisions guided by an in-depth analysis of market conditions, interest rate movements, and credit risk assessments. This active management allows the fund to adapt its investment strategies in real-time, aiming to optimize returns for investors by carefully selecting securities that offer the best risk-reward profiles within the scope of its investment mandate.

  • Maturity Management

    In line with its strategy to balance yield and risk, the fund maintains a keen focus on managing the maturity profiles of its portfolio's securities. By aiming to keep a dollar-weighted average portfolio maturity of zero to ten years, the fund strategically positions itself to mitigate interest rate risk while attempting to secure attractive yields for its investors. This approach underscores the fund's commitment to providing a thoughtful investment solution that caters to the varying risk tolerances and investment horizons of its clientele.

Contact Information

Address: -
Phone: 800-617-0004